Senior Director, Oncology Field Access & Reimbursement Strategy Lead

WHY PFIZER ONCOLOGYPfizer Commercial Oncology is introducing the world to the next era of cancer care. With a growing portfolio of novel therapies, industry-leading R&D, and a goal of delivering eight breakthroughs by 2030 across major cancer types, we're translating cutting-edge science into market-shaping impact. Here, you'll partner with exceptional colleagues across scientific, medical, and manufacturing teams, backed by advanced digital and AI-enabled infrastructure and the authority to accelerate medicines from discovery to delivery. Guided by our values of courage, excellence, equity, and joy, you'll have the opportunity to stretch your skills and build a career that evolves with you—across teams, roles, and the Pfizer enterprise. Join us to make history — for patients, for their families, for the future. ROLE SUMMARYThe National Field Reimbursement Lead is responsible for transforming Pfizer Oncology's field reimbursement strategy to meet the demands of a portfolio that spans oral oncolytics (Part D) and physician-administered, infused therapies (Part B/buy & bill). This senior leader must be fluent across both reimbursement environments sustaining support for priority oral assets while building out buy & bill capabilities required for launches and the next generation of infused oncology therapies. This leader will own the national vision and execution for access and reimbursement across a 25+ person field team, serve as the enterprise champion for AI-enabled reimbursement infrastructure, and leading a team focusing on working to ensure that post-prescription patients are initiating and staying on therapy in a manner that supports optimal outcomes on our key brands. The role reports directly to the VP, Oncology Patient Solutions & Alliances and will serve as a member of the OPSA Leadership TeamROLE RESPONSIBILITIESStrategic Leadership & National VisionDefine and execute the national field reimbursement strategy aligned to Pfizer Oncology's evolving buy & bill and infused portfolio prioritiesLead the transformation roadmap: build the capabilities and infrastructure to meet providers and patients wherever the evolving portfolio requires — in close collaboration with the Commercial Oncology Leadership Team and aligned to priority brands — without presupposing a fixed structural orientation before that work is doneServe as primary liaison to the VP and OPSA Leadership Team on field access trends, team performance, and market intelligencePartner with Marketing, Brand, US Market Access & Patient Support Services (USMA+PSS) and Customer Engagement Platform (CEP) teams to align reimbursement strategy with launch plans, Op Plans, and portfolio milestonesEvolve team to provide a mix of a proactive and reactive support health system–first engagement model, in support of patient-first partnershipDesign and Execute aligned field reimbursement support for critical launches.Support, Motivate and Mentor an award-winning field reimbursement team – both Field Reimbursement Directors (FRD) and Patient Access Navigators (PAN) – to continue to activate with urgency and integrity.Buy & Bill and Medical Benefit ExpertiseProvide subject matter expertise on medical benefit reimbursement, J-code/HCPCS coding, HOPPS billing, infusion billing/coding, and site-of-care dynamicsGuide FRD teams through the complexity of buy & bill launches, including lack of product-specific J-codes, claim denial risk mitigation, and provider reimbursement confidenceOversee the team's proficiency development in prior authorization, peer-to-peer support, appeal construction, and denial trend analyticsEnsure readiness across all reimbursement pathways—commercial, Medicare, Medicaid, 340B—for the full Pfizer Oncology portfolio including IV, injectable, and oral productsHealth System & IDN EngagementLead strategy for engaging Integrated Delivery Networks (IDNs), academic medical centers, and health systems through structured account planning, quarterly business reviewsDevelop and implement P&T committee engagement frameworks and formulary management protocols for relevant accountsGuide multi-site coordination across community, hospital outpatient, and academic settings to ensure consistent reimbursement supportOversee territory redesign as necessary to align FRD coverage with IDN footprint and health system prioritiesAnalytics, AI & Digital IntegrationChampion adoption of AI-enabled tools including Coach 360, automated denial analysis, and predictive patient-access modeling across the field teamOversee deployment of real-time territory dashboards and claims-based denial trend reporting to evolve teams account prioritizationDrive EHR and digital integration priorities including (eg. CoverMyMeds PA automation, FHIR-based benefit verification and emerging patient-centered technologies) in partnership with our Digital teamPartner with OPSA Analytics, USMA, and the PSS Data Aggregator team to build a systematic payer policy intelligence functionServe as OPSA LT sponsor for Field Execution and Innovation, including oversight of the new Field Innovation & Automation roleTeam Leadership & People DevelopmentDirectly manage Regional FRD Team Leads and PANs with indirect oversight of Enablement Field ReimbursementLead talent assessment, reskilling curriculum oversight, and structured certification program (buy & bill competencies) across the +25 person teamDrive recruiting, hiring, performance management, diversity initiatives, and succession planning across the field organizationImplement and model Pfizer's Purpose Blueprint, Ambitions, Bold Moves, and Values; lead Action Plans from PLI survey resultsBuild a compliant, high-performance culture aligned with all Pfizer policies, procedures, and relevant CMS/OIG regulationsLead team in continuity of high-functioning FRD mentorship program for growth and potential promotion of emerging talentCross-Functional Collaboration & Market IntelligenceLead cross-functional engagement with USMA+PSS, Oncol